Alzheimers Dement

1. AMIRI S, Keffeler JI, Crain DR, Denney JT, et al
   Racial, ethnic, and rural disparities in distance to physicians among decedents with Alzheimer's disease and related dementias in Washington State.
   Alzheimers Dement. 2024 Mar 20. doi: 10.1002/alz.13756.
   

   >> Share

   
   
2. HUANG SY, Zhang YR, Guo Y, Du J, et al
   Glymphatic system dysfunction predicts amyloid deposition, neurodegeneration, and clinical progression in Alzheimer's disease.
   Alzheimers Dement. 2024 Mar 19. doi: 10.1002/alz.13789.
   

   >> Share

   
   
3. CHEN K, Ghisays V, Luo J, Chen Y, et al
   Harmonizing florbetapir and PiB PET measurements of cortical Abeta plaque burden using multiple regions-of-interest and machine learning techniques: An alternative to the Centiloid approach.
   Alzheimers Dement. 2024;20:2165-2172.
   

   >> Share

   
   
4. ALDECOA I, Barroeta I, Carroll SL, Fortea J, et al
   Down Syndrome Biobank Consortium: A perspective.
   Alzheimers Dement. 2024;20:2262-2272.
   

   >> Share

   
   
5. JACK CR JR, Wiste HJ, Algeciras-Schimnich A, Weigand SD, et al
   Comparison of plasma biomarkers and amyloid PET for predicting memory decline in cognitively unimpaired individuals.
   Alzheimers Dement. 2024;20:2143-2154.
   

   >> Share

   
   
6. WILKS H, Benzinger TLS, Schindler SE, Cruchaga C, et al
   Predictors and outcomes of fluctuations in the clinical dementia rating scale.
   Alzheimers Dement. 2024;20:2080-2088.
   

   >> Share

   
   
7. ZHOU L, Nguyen TD, Chiang GC, Wang XH, et al
   Parenchymal CSF fraction is a measure of brain glymphatic clearance and positively associated with amyloid beta deposition on PET.
   Alzheimers Dement. 2024;20:2047-2057.
   

   >> Share

   
   
8. SEXTON CE, Bitan G, Bowles KR, Brys M, et al
   Novel avenues of tau research.
   Alzheimers Dement. 2024;20:2240-2261.
   

   >> Share

   
   
9. ROBINSON CG, Lee J, Min PH, Przybelski SA, et al
   Significance of a positive tau PET scan with a negative amyloid PET scan.
   Alzheimers Dement. 2024;20:1923-1932.
   

   >> Share

   
   
10. SATIZABAL CL, Beiser AS, Fletcher E, Seshadri S, et al
    A novel neuroimaging signature for ADRD risk stratification in the community.
    Alzheimers Dement. 2024;20:1881-1893.
    

    >> Share

    
    
11. MOONEN JEF, Haan R, Bos I, Teunissen C, et al
    Contributions of amyloid beta and cerebral small vessel disease in clinical decline.
    Alzheimers Dement. 2024;20:1868-1880.
    

    >> Share

    
    
12. RIVIERE ME, Langbaum JB, Turner RS, Rinne JO, et al
    Effects of the active amyloid beta immunotherapy CAD106 on PET measurements of amyloid plaque deposition in cognitively unimpaired APOE epsilon4 homozygotes.
    Alzheimers Dement. 2024;20:1839-1850.
    

    >> Share

    
    
13. OLTRA J, Habich A, Schwarz CG, Nedelska Z, et al
    Sex differences in brain atrophy in dementia with Lewy bodies.
    Alzheimers Dement. 2024;20:1815-1826.
    

    >> Share

    
    
14. CHEN Y, Spina S, Callahan P, Grinberg LT, et al
    Pathology-specific patterns of cerebellar atrophy in neurodegenerative disorders.
    Alzheimers Dement. 2024;20:1771-1783.
    

    >> Share

    
    
15. SANCHEZ E, Wilkinson T, Coughlan G, Mirza S, et al
    Association of plasma biomarkers with cognition, cognitive decline, and daily function across and within neurodegenerative diseases: Results from the Ontario Neurodegenerative Disease Research Initiative.
    Alzheimers Dement. 2024;20:1753-1770.
    

    >> Share

    
    
16. SUN X, Eastman G, Shi Y, Saibaba S, et al
    Structural and functional damage to neuronal nuclei caused by extracellular tau oligomers.
    Alzheimers Dement. 2024;20:1656-1670.
    

    >> Share

    
    
17. KOTAH JM, Kater MSJ, Brosens N, Lesuis SL, et al
    Early-life stress and amyloidosis in mice share pathogenic pathways involving synaptic mitochondria and lipid metabolism.
    Alzheimers Dement. 2024;20:1637-1655.
    

    >> Share

    
    
18. ROYALL DR, Palmer RF
    Statin use moderates APOE's and CRP's associations with dementia and is associated with lesser dementia severity in epsilon4 carriers.
    Alzheimers Dement. 2024;20:1627-1636.
    

    >> Share

    
    
19. STITES SD, Largent EA, Schumann R, Harkins K, et al
    How reactions to a brain scan result differ for adults based on self-identified Black and White race.
    Alzheimers Dement. 2024;20:1527-1537.
    

    >> Share

    
    
20. ROYSE SK, Snitz BE, Hengenius JB, Huppert TJ, et al
    Unhealthy white matter connectivity, cognition, and racialization in older adults.
    Alzheimers Dement. 2024;20:1483-1496.
    

    >> Share

    
    
21. LARSEN FK, Baksh RA, McGlinchey E, Langballe EM, et al
    Age of Alzheimer's disease diagnosis in people with Down syndrome and associated factors: Results from the Horizon 21 European Down syndrome consortium.
    Alzheimers Dement. 2024 Mar 20. doi: 10.1002/alz.13779.
    

    >> Share

    
    
22. WANG Y, Sarnowski C, Lin H, Pitsillides AN, et al
    Key variants via the Alzheimer's Disease Sequencing Project whole genome sequence data.
    Alzheimers Dement. 2024 Mar 21. doi: 10.1002/alz.13705.
    

    >> Share

    
    

    
    Am J Alzheimers Dis Other Demen

23. LIU B, Luo W, Huang L, Wei C, et al
    Migration Inhibition Factor Secreted by Peripheral Blood Memory B Cells Binding to CD74-CD44 Receptor Complex Drives Macrophage Behavior in Alzheimer's Disease.
    Am J Alzheimers Dis Other Demen. 2024;39:15333175241238577.
    

    >> Share

    
    

    
    BMC Geriatr

24. BARONE R, Bramato G, Gnoni V, Giugno A, et al
    Sarcopenia in subjects with Alzheimer's disease: prevalence and comparison of agreement between EGWSOP1, EGWSOP2, and FNIH criteria.
    BMC Geriatr. 2024;24:278.
    

    >> Share

    
    

    
    BMC Neurol

25. SHEN M, Zhang L, Chen C, Wei X, et al
    Investigating the causal relationship between immune cell and Alzheimer's disease: a mendelian randomization analysis.
    BMC Neurol. 2024;24:98.
    

    >> Share

    
    

    
    Curr Alzheimer Res

26. HASKOLOGLU IC, Erdag E, Sehirli AO, Uludag O, et al
    Beyond Conventional Therapies: Molecular Dynamics of Alzheimer's Treatment through CLOCK/BMAL1 Interactions.
    Curr Alzheimer Res. 2024 Mar 19. doi: 10.2174/0115672050301014240315065235.
    

    >> Share

    
    

    
    J Am Geriatr Soc

27. WILLIAMS-FARRELLY MM, Schroeder MW, Li C, Perkins AJ, et al
    Loneliness in older primary care patients and its relationship to physical and mental health-related quality of life.
    J Am Geriatr Soc. 2024;72:811-821.
    

    >> Share

    
    
28. JUTKOWITZ E, Shewmaker P, Ford CB, Smith VA, et al
    Association between results of an amyloid PET scan and healthcare utilization in individuals with cognitive impairment.
    J Am Geriatr Soc. 2024;72:707-717.
    

    >> Share

    
    

    
    J Neurosci

29. YE Q, Gast G, Wilfley EG, Huynh H, et al
    Monosynaptic rabies tracing reveals sex- and age-dependent dorsal subiculum connectivity alterations in an Alzheimer's disease mouse model.
    J Neurosci. 2024 Mar 19:e1796232024. doi: 10.1523/JNEUROSCI.1796-23.2024.
    

    >> Share

    
    

    
    N Engl J Med

30. CHIN NA, Dinsmore D, Gonzales T, Groves B, et al
    Alzheimer's Disease - Managing Stages of Dementia.
    N Engl J Med. 2024;390:e29.
    

    >> Share

    
    

    
    Nat Med

31. O'LEARY K
    A timeline of biomarker changes before Alzheimer's disease.
    Nat Med. 2024 Mar 15. doi: 10.1038/d41591-024-00018.
    

    >> Share

    
    

    
    Neurobiol Aging

32. LOPEZ S, Hampel H, Chiesa PA, Del Percio C, et al
    The association between posterior resting-state EEG alpha rhythms and functional MRI connectivity in older adults with subjective memory complaint.
    Neurobiol Aging. 2024;137:62-77.
    

    >> Share

    
    
33. NAUDE J, Wang M, Leon R, Smith E, et al
    Tau-PET in early cortical Alzheimer brain regions in relation to mild behavioral impairment in older adults with either normal cognition or mild cognitive impairment.
    Neurobiol Aging. 2024;138:19-27.
    

    >> Share

    
    
34. POOLE VN, Ridwan AR, Arfanakis K, Dawe RJ, et al
    Associations of brain morphology with cortical proteins of cognitive resilience.
    Neurobiol Aging. 2024;137:1-7.
    

    >> Share

    
    

    
    Neurobiol Dis

35. BONIFAZI G, Luchena C, Gaminde-Blasco A, Ortiz-Sanz C, et al
    A nonlinear meccano for Alzheimer's emergence by amyloid beta-mediated glutamatergic hyperactivity.
    Neurobiol Dis. 2024 Mar 15:106473. doi: 10.1016/j.nbd.2024.106473.
    

    >> Share

    
    

    
    Neurology

36. CAI Y, Shi D, Lan G, Chen L, et al
    Association of beta-Amyloid, Microglial Activation, Cortical Thickness, and Metabolism in Older Adults Without Dementia.
    Neurology. 2024;102:e209205.
    

    >> Share

    
    
37. BUCHMAN AS, Yu L, Klein HU, Zammit AR, et al
    Glycoproteome-Wide Discovery of Cortical Glycoproteins That May Provide Cognitive Resilience in Older Adults.
    Neurology. 2024;102:e209223.
    

    >> Share

    
    

    
    Neurosci Lett

38. CHEN J, Su C, Ma Z, Ou X, et al
    Aerobic exercise suppresses cognitive injury in patients with Alzheimer's disease by regulating long non-coding RNA TUG1.
    Neurosci Lett. 2024;826:137732.
    

    >> Share

    
    
39. FENG Q, Li X, Liu R, Liu G, et al
    Overexpression of MTMR14 induced learning and memory impairments in 2-month-old C57 mice.
    Neurosci Lett. 2024;825:137700.
    

    >> Share

    
    

    
    Neuroscience

40. MEHMOOD A, Shahid F, Khan R, Ibrahim MM, et al
    Utilizing Siamese 4D-AlzNet and Transfer Learning to Identify Stages of Alzheimer's Disease.
    Neuroscience. 2024 Mar 14:S0306-4522(24)00112.
    

    >> Share

    
    

    
    PLoS One

41. ABAYOMI SN, Sritharan P, Yan E, Saripella A, et al
    The diagnostic accuracy of the Mini-Cog screening tool for the detection of cognitive impairment-A systematic review and meta-analysis.
    PLoS One. 2024;19:e0298686.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share